Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 565 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: CT Scans Clear all

Conditions: Computed Tomography
Interventions: Investigational CT Scan; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma
Interventions: 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1, Metastatic Carcinoid Tumor
Interventions: Dual-Energy Computed Tomography; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Coronary Artery Disease, Aortic Aneurysm, Pulmonary Embolism
Interventions: Not listed
Lead sponsor: Gilbert L. Raff, MD; Other
Eligibility: 18 Years and older
Enrollment: 2,640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 8
States / cities: San Diego, California • Boston, Massachusetts • Royal Oak, Michigan + 5 more

Conditions: High Risk of Developing Lung Cancer
Interventions: CT scan & Early CDT Lung test, CT scan & Early CDT Lung test; Radiation · Other
Lead sponsor: National Jewish Health; Other
Eligibility: 50 Years to 75 Years
Enrollment: 1,361 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Healthy
Interventions: GE-145 (AN113111) Injection, Visipaque (iodixanol) Injection; Drug
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Cerebrovascular Accident
Interventions: Reopro, Retrovase; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Lung Neoplasms, Lung Cancer
Interventions: Mobile Low-dose Computed Tomography (LDCT) Screening; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 40 Years to 54 Years
Enrollment: 1,160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Breast Cancer
Interventions: Tomosynthesis Breast Scanning, Breast CT Scanning; Radiation
Lead sponsor: University of California, Davis; Other
Eligibility: 35 Years and older · Female only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Sacramento, California

Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Interventions: Photon-counting CT, Energy-integrating CT; Device
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bladder Cancer, Urothelial Carcinoma
Interventions: 18F-fluciclovine, PET/CT; Drug · Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Intraductal Papillary Mucinous Neoplasm
Interventions: PET-CT; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Type1 Diabetes Mellitus
Interventions: 18F-fallypride; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Orange, California

Conditions: Cirrhosis, End Stage Liver Disease, Hepatitis C
Interventions: Screening; Procedure
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Routine Outpatients Undergoing Contrast Enhanced CT Scan of the Abdomen and Pelvis
Interventions: Withhold oral contrast; Other
Lead sponsor: Hartford Hospital; Other
Eligibility: 21 Years and older
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Morbid Obesity, Respiratory Failure
Interventions: low-dose chest CT scan, insertion of esophageal balloon; Radiation · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Urolithiasis
Interventions: Point-of-care Ultrasound, Radiology Ultrasound, Radiology CT; Other · Radiation
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2,776 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 15
States / cities: Fresno, California • Sacramento, California • San Francisco, California + 11 more

Conditions: Carcinoma, Squamous Cell
Interventions: FDG-PET/CT, Cetuximab; Procedure · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 2
States / cities: Louisville, Kentucky • St Louis, Missouri

Conditions: Lung Cancer, Abdominal Cancer
Interventions: Motion CT Scans; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Family History of Lung Cancer
Interventions: CT scan, Sybil; Diagnostic Test · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2035
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cocaine Dependence
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 55 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Atrial Fibrillation
Interventions: Transesophageal Echocardiography; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Flu
Interventions: FluShield, FluShield - same arm, FluShield - opposite arm, Blood Draws, FDG PET-CT Scan, Cytokine Profiling; Biological · Procedure · Genetic
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 21 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Mild Traumatic Brain Injury
Interventions: VIDAS® TBI Test [GFAP and UCH-L1 assays]; Diagnostic Test
Lead sponsor: BioMérieux; Industry
Eligibility: 18 Years and older
Enrollment: 903 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 5
States / cities: Orlando, Florida • Detroit, Michigan • Rochester, Minnesota + 2 more

Search by objective public record fields.

Next Generation CT System

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

ReoPro and Retavase to Treat Acute Stroke

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis

Photon-counting CT in Chest Imaging

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm

PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

The Impact of Oral Contrast in Multidetector CT of the Abdomen and Pelvis on Radiologist Confidence

Comparison of Esophageal Manometry and CT Scan Measurements

Study of Tomography of Nephrolithiasis Evaluation

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

Respiratory Tumor and Normal Tissue Motion

LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A

Impulsivity, Neural Deficits and Cocaine Addiction

Safety Monitoring of Patients Having Pulmonary Vein Ablation

PET-CT Scans in Healthy Volunteers After Flu Vaccination

VIDAS® TBI Real Life Performance in Subjects With Mild Traumatic Brain Injury (mTBI)